# Mayur Abhaya

> Mayur Abhaya is a seed investor in Kanchipuram backing Apps and Medical. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Location: Kanchipuram, India
- Total investments: 2
- Last investment: May 2018
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/mayur-abhaya-87940561/

Mayur Abhaya is a seed investor in Kanchipuram focused on Apps and Medical. Mayur Abhaya is the CEO & Managing Director of LifeCell and has transformed the organization to a multi-service stem cell solutions provider.He was instrumental in the launch of many new services at the organization such as BabyCord Duo - umbilical cord tissue banking, LifeCell Femme - menstrual blood stem cell banking, cord tissue stem cellexpansion and the launch of BabyShield, the world’s most advanced newborn screening service.He introduced pioneering programs within the company and the industry through several exclusive value-added innovations such as personalized shipment of the sample, disaster relief program, LifeCell Cares program, quality guarantee program and dual storage. Mayur Abhaya persistent efforts and commitment towards quality ensured LifeCell received prestigious international accreditations.Leading a dedicated team of professionals, Mayur Abhaya expanded LifeCell’s operations to GCC countries and abroad. He steered the organizations growth by expanding the company’s network to over 200 centers across the country. LifeCell has acquired significant market share and has continued to strengthen its leadership position. In 2013, under Mayur Abhaya able leadership, LifeCell secured an investment of Rs.35 crore from Helion Venture Partners, an India focused venture fund. Today, the company has over 1,500,000 customers who have banked with LifeCell, a first in the industry.Mayur Abhaya comes with the experience of working at Shasun Chemicals and has held key responsibilities such as intellectual property & licensing, generics, acquisitions and implementation of various IT systems.

## Contacts

5 contacts available for Mayur Abhaya: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/mayur-abhaya?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Apps | 1 | 50% |
| Medical | 1 | 50% |
| Hospital | 1 | 50% |
| Health Care | 1 | 50% |
| Artificial Intelligence | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series A | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| mfine | Mfine is an health-tech startup that offers an AI-powered online doctor consultation app. Their doctors have access to a proprietary Assistive Intelligence platform that can analyze the symptoms and deliver accurate prognosis for the specialist to assess patients. This means, the doctor knows about patients' condition even before they’ve seenthem, making the diagnosis quicker and sharper.Mfine aims to make access to trusted healthcare simple, fast and proactive. With a combination of new-age technology and partnerships with best in class hospitals/clinics, they designed mfine keeping consumer experience at its core. Mfine brings in instant and continuous connectivity with top doctors of the best hospitals. It uses cutting edge technology to keep track of your health parameters and keep all your health data in your control and easily accessible. Digital wearable devices, mobile app, and at-home services bring in the much-needed convenience and speed in getting you the right care when you need it.Mfine was founded in 2017 and is based in Bengaluru. | $4.2M | Series A | May 17, 2018 | https://www.mfine.co/ |
| mfine | Mfine is an health-tech startup that offers an AI-powered online doctor consultation app. Their doctors have access to a proprietary Assistive Intelligence platform that can analyze the symptoms and deliver accurate prognosis for the specialist to assess patients. This means, the doctor knows about patients' condition even before they’ve seenthem, making the diagnosis quicker and sharper.Mfine aims to make access to trusted healthcare simple, fast and proactive. With a combination of new-age technology and partnerships with best in class hospitals/clinics, they designed mfine keeping consumer experience at its core. Mfine brings in instant and continuous connectivity with top doctors of the best hospitals. It uses cutting edge technology to keep track of your health parameters and keep all your health data in your control and easily accessible. Digital wearable devices, mobile app, and at-home services bring in the much-needed convenience and speed in getting you the right care when you need it.Mfine was founded in 2017 and is based in Bengaluru. |  | Seed | Sep 01, 2017 | https://www.mfine.co/ |

2 of 2 investments shown.

## Co-investors
- [Prime Venture Partners](https://shizune.co/investors/profile/angelprime) — VC Fund, 2 deals together
- [Stellaris Venture Partners](https://shizune.co/investors/profile/stellaris-venture-partners) — VC Fund, 2 deals together
- [BEENEXT](https://shizune.co/investors/profile/bee-next) — VC Fund, 1 deal together
- [OCTAVE Capital](https://shizune.co/investors/profile/heritas-capital-management) — VC Fund, 1 deal together
- [SBI Investment](https://shizune.co/investors/profile/sbi-investment-2) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Titan Capital](https://shizune.co/investors/profile/titan-capital) — VC Fund
- [Inflection Point Ventures](https://shizune.co/investors/profile/inflection-point-ventures-d275) — VC Fund
- [Blume Ventures](https://shizune.co/investors/profile/blume-ventures) — VC Fund

## Featured in investor lists
- [Medical Angel Investors in India](https://shizune.co/investors/medical-angel-investors-india)

## FAQ

### What does Mayur Abhaya invest in?

Mayur Abhaya invests primarily in Apps, Medical and Hospital startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Mayur Abhaya?

Public channels for Mayur Abhaya include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Mayur Abhaya last invest?

The most recent investment recorded for Mayur Abhaya closed in May 2018. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co